An angiogenic role for the neurokines midkine and pleiotrophin in tumorigenesis

Cancer Research

Volumn 57, Issue 9, 1997, Pages 1814-1819

  Choudhuri, Rangana ^a   Zhang, Hua Tang ^a   Donnini, Sandra ^b   Ziche, Marina ^b   Bicknell, Roy ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; CD31 ANTIGEN; HEPARIN BINDING PROTEIN; MIDKINE; PLEIOTROPHIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CARCINOGENESIS; CARCINOMA CELL; CONTROLLED STUDY; CORNEA; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RABBIT; TUMOR GROWTH;

ANIMALS; ANTIGENS, CD31; CARRIER PROTEINS; CELL DIVISION; CYTOKINES; ENDOTHELIUM, VASCULAR; FEMALE; GROWTH SUBSTANCES; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; RABBITS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0030904197     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Bohlen, P., and Kovesdi, I. HBGF and MK, members of a novel gene family of heparin-binding proteins with potential roles in embryogenesis and brain function. Prog. Growth Factor Res., 3: 143-157, 1991.
2. Mitsiadis, T. A., Salmivirta, M., Muramatsu, T., Muramatsu, H., Rauvala, H., Lehtonen, E., Jalkanen, M., and Thesleff, I. Expression of the heparin-binding cytokines, midkine (MK) and HB-GAM (pleiotrophin) is associated with epithelial-mesenchymal interactions during fetal development and organogenesis. Development, 121: 37-51, 1995.
3. Kadomatsu, K., Huang, R. P., Suganuma, T., Murata, F., and Muramatsu, T. A retinoic acid responsive gene MK found in the teratocarcinoma system is expressed in spatially and temporally controlled manner during mouse embryogenesis. J. Cell Biol., 110: 607-616, 1990.
4. Wanaka, A., Carroll, S. L., and Milbrandt, J. Developmentally regulated expression of pleiotrophin, a novel heparin binding growth factor, in the nervous system of the rat. Brain Res. Dev. Brain Res. Rev., 72: 133-144, 1993.
5. Bloch, B., Normand, E., Kovesdi, I., and Bohlen, P. Expression of the HBNF (heparin-binding neurite-promoting factor) gene in the brain of fetal, neonatal and adult rat: an in situ hybridization study. Brain Res. Dev. Brain Res. Rev., 70: 267-278, 1992.
6. Nakagawara, A., Milbrandt, J., Muramatsu, T., Deuel, T. F., Zhao, H., Cnaan, A., and Brodeur, G. M. Differential expression of pleiotrophin and midkine in advanced neuroblastomas. Cancer Res., 55: 1792-1797, 1995.
7. Tsutsui, J-I., Kadomatsu, K., Matsubara, S., Nakagawara, A., Hamanoue, M., Takao, S., Shimazu, H., and Muramatsu, T. A new family of heparin-binding growth/ differentiation factors: increased midkine expression in Wilms' tumor and other human carcinomas. Cancer Res., 53: 1281-1285, 1993.
8. Riegel, A. T., and Wellstein, A. The potential role of the heparin-binding growth factor pleiotrophin in breast cancer. Breast Cancer Res. Treat., 31: 309-314, 1994.
9. Garver, R. I., Radford, D. M., Doris-Kellen, H., Wick, M. R., and Milner, P. G. Midkine and pleiotrophin expression in normal and malignant tissue. Cancer (Phila.), 74: 1584-1590, 1994.
10. O'Brien, T., Cranston, D., Fuggle, S., Bicknell, R., and Harris, A. L. The angiogenic factor midkine is expressed in bladder cancer and overexpression correlates with a poor outcome in patients with invasive cancers. Cancer Res., 56: 2515-2518, 1996.
11. Czubayko. F., Riegel, A. T., and Wellstein, A. Ribozyme-targeting elucidates a direct role of pleiotrophin in tumor growth. J. Biol. Chem., 269: 21358-21363, 1994.
12. Jaffe, E. J., Nachman, R. L., Becker, C. G., and Minick, R. C. Culture of human endothelial cells derived from umbilical veins: identification by morphologic and immunologic criteria. J. Clin. Invest., 52: 2745-2756, 1973.
13. Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., and Struhl, K. Current Protocols in Molecular Biology. New York: John Wiley & Sons, Inc., 1987.
14. Gimbrone, M. A., Jr., Cotran, R. S., Leapman, S. A. B., and Folkman, J. Tumor growth and neovascularisation: an experimental model using the rabbit cornea. J. Natl. Cancer Inst., 52: 413-427, 1974.
15. Ziche, M. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J. Clin. Invest., 94: 2036-2044, 1994.
16. Zhang, H-T., Craft, P., Scott, P. A. E., Ziche, M., Weich, H. A., Harris, A. L., and Bicknell, R. Enhancement of tumor growth and vascular density by transfection of vascular endothelial growth factor into MCF-7 breast carcinoma cells. J. Natl. Cancer Inst., 87: 213-219, 1995.
17. Toi, M., Harris, A. L., and Bicknell, R. cDNA transfection followed by the isolation of a MCF-7 breast cell line resistant to tamoxifen in vitro and in vivo. Br. J. Cancer, 68: 1088-1096, 1993.
18. Attia, M. A. M., and Weiss, D. W. Immunology of spontaneous mammary carcinoma in mice. V. Acquired tumor resistance and enhancement in strain A mice infected with mammary tumor virus. Cancer Res., 26: 1787-1800, 1966.
19. Vecchi, A., Garlanda, D., Lampugnani, M. G., Resnati, M., Stoppacciaro, A., Ruco, L., Mantovani, A., and Dejana, E. Monoclonal antibodies specific for endothelial cells of mouse blood vessels. Their application in the identification of adult and embryonic endothelium. Eur. J. Cell Biol., 63: 247-254, 1994.
20. Fox, S. B., Leek, R. D., Weekes, M. P., Whitehouse, R. M., Gatter, K. C., and Harris, A. L. Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count and computer image analysis. J. Pathol., 177: 275-283, 1995.
21. Fang, W., Hartmann, N., Chow, D. T., Riegel, A. T., and Wellstein, A. Pleiotrophin stimulates fibroblasts and endothelial and epithelial cells and is expressed in human cancer. J. Biol. Chem., 267: 25889-25897, 1992.
22. Moghaddam, A., Zhang, H-T., Fan, T-P. D., Hu, D-E., Lees, V. C., Turley, H., Fox, S. B., Gatter, K. C., Harris, A. L., and Bicknell, R. Thymidine phosphorylase is angiogenic and promotes tumour growth. Proc. Natl. Acad. Sci. USA, 92: 998-1002, 1995.
23. Less, J. R., Skalak, T. C., Sevick, E. M., and Jain, R. K. Microvascular architecture in a mammary carcinoma: branching patterns and vessel dimensions. Cancer Res., 51: 265-273, 1991.
24. Laaroubi, K., Delbe, J., Vacherort, F., Desgranges, P., Tardieu, M., Jaye, M., Barritault, D., and Courty, J. Mitogenic and in vitro angiogenic activity of human recombinant heparin affin regulatory peptide. Growth Factors, 10: 89-98, 1994.
25. Weidner, N. Tumor angiogenesis: a new significant and prognostic indicator in early-stage breast carcinoma. J. Natl. Cancer Inst., 84: 1875-1887, 1992.
26. Chaplain, M. A. J. Reaction-diffusion prepatterning and its potential role in tumour invasion. J. Biol. Systems, 3: 929-936, 1995.
27. Alon, T., Itzhak, H., Itin, A., Pe'er, J., Stone, J., and Keshet, E. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat. Med., 1: 1024-1028, 1995.
28. Raulo, E., Chernousor, M. A., Carey, D. J., Nolo, R., and Rauvala, H. Isolation of a neuronal cell-surface receptor of heparin binding growth-associated molecule (HB-GAM). Identification as N-syndecan (syndecan-3). J. Biol. Chem. 269: 12999-13004, 1994.